196 related articles for article (PubMed ID: 11385512)
1. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection.
Stewart GR; Snewin VA; Walzl G; Hussell T; Tormay P; O'Gaora P; Goyal M; Betts J; Brown IN; Young DB
Nat Med; 2001 Jun; 7(6):732-7. PubMed ID: 11385512
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
[TBL] [Abstract][Full Text] [Related]
3. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis.
Brzostek A; Dziadek B; Rumijowska-Galewicz A; Pawelczyk J; Dziadek J
FEMS Microbiol Lett; 2007 Oct; 275(1):106-12. PubMed ID: 17651430
[TBL] [Abstract][Full Text] [Related]
5. The Mycobacterium tuberculosis SigD sigma factor controls the expression of ribosome-associated gene products in stationary phase and is required for full virulence.
Calamita H; Ko C; Tyagi S; Yoshimatsu T; Morrison NE; Bishai WR
Cell Microbiol; 2005 Feb; 7(2):233-44. PubMed ID: 15659067
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
[TBL] [Abstract][Full Text] [Related]
9. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
10. The AraC family transcriptional regulator Rv1931c plays a role in the virulence of Mycobacterium tuberculosis.
Frota CC; Papavinasasundaram KG; Davis EO; Colston MJ
Infect Immun; 2004 Sep; 72(9):5483-6. PubMed ID: 15322050
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
Fan X; Gao Q; Fu R
Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
[TBL] [Abstract][Full Text] [Related]
13. Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissues.
Lamichhane G; Raghunand TR; Morrison NE; Woolwine SC; Tyagi S; Kandavelou K; Bishai WR
J Infect Dis; 2006 Nov; 194(9):1233-40. PubMed ID: 17041849
[TBL] [Abstract][Full Text] [Related]
14. Interaction of pathogenic mycobacteria with the host immune system.
Houben EN; Nguyen L; Pieters J
Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
[TBL] [Abstract][Full Text] [Related]
15. Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator.
Uchida Y; Casali N; White A; Morici L; Kendall LV; Riley LW
Cell Microbiol; 2007 May; 9(5):1275-83. PubMed ID: 17223927
[TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
17. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A
FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis: the genetics of vulnerability.
Jabado N; Gros P
Nature; 2005 Apr; 434(7034):709-11. PubMed ID: 15815612
[No Abstract] [Full Text] [Related]
20. Absence of complement receptor 3 results in reduced binding and ingestion of Mycobacterium tuberculosis but has no significant effect on the induction of reactive oxygen and nitrogen intermediates or on the survival of the bacteria in resident and interferon-gamma activated macrophages.
Rooyakkers AW; Stokes RW
Microb Pathog; 2005 Sep; 39(3):57-67. PubMed ID: 16084683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
